Every 8-K that Keen Vision Acquisition Corporation (KVAC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow KVAC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KVAC filings page.
Keen Vision Acquisition Corporation reported that Nasdaq notified it on July 27, 2026 that its units, ordinary shares, and warrants will be suspended and delisted from the Nasdaq Global Market for failing to meet listing standards, including key special purpose acquisition company requirements.
The notice cites non-compliance with Nasdaq IM-5101-2, which requires completing a business combination within 36 months of IPO registration effectiveness, and minimum thresholds of 1,100,000 publicly held shares and 400 total holders. Trading is scheduled to be suspended on August 3, 2026, with a Form 25-NSE to remove the securities from listing and registration. The company will not appeal and expects its securities to trade over-the-counter, intending to seek a new Nasdaq listing in connection with a potential business combination.
Keen Vision Acquisition Corporation (KVAC) obtained shareholder approval to amend its Investment Management Trust Agreement and charter, giving the SPAC the right to extend its business combination period up to four additional times, each for three months, from July 27, 2026 to July 27, 2027, by depositing $30,000 into the trust account for each extension.
KVAC issued an unsecured $30,000 promissory note to KVC Sponsor LLC on July 24, 2026 in exchange for the sponsor funding the initial extension payment; the note bears no interest, matures at the closing of a business combination, and may be converted into units at $10.00 per unit. The company filed its fifth amended and restated memorandum and articles of association on July 23, 2026. At the July 21, 2026 extraordinary general meeting, 5,227,979 of 5,506,521 entitled shares (about 95.85%) were represented, both the trust and charter amendments passed with 4,982,736 votes in favor, and 935,966 shares were tendered for redemption. KVAC has deposited the initial $30,000 to extend its business combination deadline to October 27, 2026.
Keen Vision Acquisition Corporation entered into a financing arrangement with its sponsor to extend the time it has to complete a business combination.
On April 21, 2026, the company issued an unsecured promissory note for $120,000 to KVC Sponsor LLC. The sponsor deposited the same amount into the company’s trust account, allowing the business combination deadline to be extended. The note bears no interest and becomes due at the closing of a business combination. The holder may convert the note into units identical to the IPO units at $10.00 per unit. By depositing $120,000 into the trust account on April 27, 2026, the company extended its business combination period to July 27, 2026.
Keen Vision Acquisition Corporation reported that it amended its binding letter of intent with Medera Inc. and its subsidiary Novoheart Group Limited. The amendment moves the target date to sign a new replacement merger agreement from April 10, 2026 to April 30, 2026.
The prior merger agreement dated September 3, 2024 had already been terminated and replaced by this letter of intent. The parties continue to use their best efforts to finalize and execute the replacement merger agreement by the new deadline.
Keen Vision Acquisition Corporation entered into a binding letter of intent with Medera Inc. and its subsidiary Novoheart Group Limited (NVH) to negotiate a replacement merger agreement. The new deal would combine NVH, a pre-clinical human disease modeling and drug discovery business, with Keen Vision, which would remain Nasdaq-listed.
The LOI sets NVH’s enterprise valuation at US$100,000,000 and requires the surviving company to have at least US$10,000,000 of available cash at closing after expenses and NVH-related debt. Cash expenses paid at closing are capped at US$700,000 for Keen Vision and US$1,300,000 for NVH, with liquidity coming from the trust account after redemptions, any PIPE financing, and NVH’s cash.
The parties aim to sign the replacement merger agreement by April 10, 2026, with closing conditions largely mirroring a prior merger agreement that has now been terminated under a mutual release. The deal must close within nine months of the LOI, and any PIPE fundraising must also be completed within nine months of signing.
Keen Vision Acquisition Corporation updated investors on its efforts to extend the time available to complete a business combination. Shareholders approved an amendment to the company’s Investment Management Trust Agreement and its memorandum and articles of association, allowing up to two additional three‑month extensions of the business combination deadline from January 27, 2026 to July 27, 2026, in each case by depositing $120,000 into the trust account.
To fund the initial extension, the sponsor provided $120,000 via an unsecured promissory note that bears no interest, matures at the closing of a business combination, and can be converted into units at $10.00 per unit. In connection with the annual meeting vote, 3,781,900 ordinary shares were tendered for redemption, and the company has deposited the initial $120,000 to extend the deadline to April 27, 2026. Shareholders also re‑elected five directors and ratified Adeptus Partners, LLC as auditor.
Keen Vision Acquisition Corporation entered into a new funding arrangement with its sponsor to gain more time to complete a merger. On November 18, 2025, the company issued an unsecured promissory note for $144,670.38 to KVC Sponsor LLC. In return, the sponsor deposited the same amount into the company’s trust account to extend the deadline for completing a business combination.
The note carries no interest and becomes due when Keen Vision closes a business combination. The sponsor may also choose to convert the note into units identical to those sold in the IPO at a price of $10.00 per unit, which ties repayment terms directly to the company’s eventual merger outcome.
Keen Vision Acquisition Corporation issued an unsecured promissory note for $144,670.38 to its sponsor in exchange for a trust deposit to extend the time to complete a business combination. The note bears no interest and matures upon the closing of a business combination. The holder may convert the note into units identical to the IPO units at $10.00 per unit.
The company extended its business combination period to November 27, 2025 after depositing $144,670.38 into the trust account on October 24, 2025. Listed securities include units (KVACU), ordinary shares (KVAC), and warrants (KVACW) with a stated exercise price of $11.50 per share.
Keen Vision Acquisition Corp. filed an 8-K reporting several discrete transactional details. The company offered Units composed of one ordinary share and one redeemable warrant. The securities carry Nasdaq symbols KVACU (Units), KVAC (Ordinary Shares) and KVACW (Warrants). The disclosed warrants are exercisable for one ordinary share at an exercise price of $11.50. The filing also references a Promissory Note dated September 19, 2025. The document is signed by Chief Executive Officer Kenneth Ka Chun Wong.